News ArticleBlue Star Limited Announces Unaudited Consolidated Financial Results for Q2 and H1 2026 Reviewed by Deloitte
Board approved results for the quarter and half year ended September 30, 2026, including subsidiaries and joint ventures under Indian Accounting Standards.
Blue Star Limited announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The financial statements include subsidiary and joint venture results, have been reviewed by Deloitte Haskins & Sells LLP, and are prepared under Indian Accounting Standards as mandated by SEBI listing regulations.
Blue Star Limited
Financial Results
Blue Star Limited's Board approved the unaudited standalone and consolidated financial results for Q2 and half year ending September 30, 2026, including results of subsidiaries and joint ventures, reviewed by Deloitte Haskins & Sells LLP.
The results were approved in the Board meeting held on October 29, 2026, and include subsidiaries such as Blue Star Engineering & Electronics Limited, Blue Star Climatech Limited, and international entities like Blue Star Qatar W.L.L. and Blue Star Europe B.V.
The consolidated financial statements comply with Indian Accounting Standard (Ind AS) 34 requirements and SEBI Listing Obligations and Disclosure Regulations. The independent auditor Deloitte Haskins & Sells LLP reviewed the interim financial results in accordance with applicable Standards on Review Engagements.
Some subsidiaries' financials, particularly those outside India, were prepared under local accounting principles and converted to Indian GAAP by the company management; these adjustments were reviewed by the auditors.
One subsidiary's interim results were not reviewed by auditors but included in the consolidated financials. The group’s share of profits from joint ventures was also incorporated as per their financial information.
Highlights
- The Board meeting took place on October 29, 2026, from 10:00 AM to 3:40 PM.
- Financial results are unaudited but have been reviewed by Deloitte Haskins & Sells LLP.
- Consolidated financials include multiple subsidiaries and joint ventures across international locations.
- The interim financials are prepared using Indian Accounting Standard 34 as per SEBI listing regulations.
- One subsidiary's financial information was unaudited but included in the consolidated results.
- Total assets of several subsidiaries considered amount to ₹437.47 crore as of September 30, 2026.
Key Data Snapshot
What happened
- Blue Star Limited's Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
- The results include financials of its subsidiaries and joint ventures inside and outside India.
- The auditor Deloitte Haskins & Sells LLP reviewed the interim results as per Indian accounting standards.
Key details
- The Board meeting started at 10:00 AM and ended at 3:40 PM on October 29, 2026.
- Financial results align with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Certain subsidiaries' financial results were originally prepared under respective local accounting principles and converted to Indian GAAP by Blue Star's management.
- One subsidiary's interim financial results were unaudited but included in consolidated results.
- The consolidated results also include the group’s share of profits from its joint ventures.
Regulatory and governance context
- Financial results prepared and filed in accordance with SEBI Listing Regulations 30 and 33.
- Interim financial statements comply with Indian Accounting Standard 34 for interim financial reporting.
- Review conducted under Standards on Review Engagement 2410 issued by ICAI.
- Limited review reports accompany the financial statements as per regulatory requirements.
Highlights
- The Board meeting took place on October 29, 2026, from 10:00 AM to 3:40 PM.
- Financial results are unaudited but have been reviewed by Deloitte Haskins & Sells LLP.
- Consolidated financials include multiple subsidiaries and joint ventures across international locations.
- The interim financials are prepared using Indian Accounting Standard 34 as per SEBI listing regulations.
- One subsidiary's financial information was unaudited but included in the consolidated results.
- Total assets of several subsidiaries considered amount to ₹437.47 crore as of September 30, 2026.
Disclosures
- Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulation 30 and 33)
- Indian Accounting Standard 34 - Interim Financial Reporting
- Standard on Review Engagements 2410 by ICAI
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Indegene Limited Announces Unaudited Consolidated and Standalone Results for Q2 and H1 Ending September 30, 2026
Indegene Limited approved its unaudited consolidated and standalone financial results for the second quarter and half year ended September 30, 2026, alongside approving allotments under RSU and ESOP schemes and key personnel resignations during its board meeting on October 29, 2026.
Read Full Story
Alivus Life Sciences Posts ₹3,568 Million Net Profit in First Half of FY2026, Q2 Net Profit at ₹1,967 Million
Alivus Life Sciences Limited has reported its unaudited financial results for the second quarter and half year ended September 30, 2026, posting a net profit of ₹1,967 million for the quarter and ₹3,568 million for the half year, supported by revenue growth.
Read Full Story
Timken India Limited Achieves Rs 2,311.94 Million Net Profit for First Half of FY 2026-27
Timken India Limited reported a net profit after tax of Rs 2,311.94 million for the half year ended September 30, 2026, with revenue from operations totaling Rs 18,983.82 million, as per its unaudited standalone financial results approved by the Board on October 29, 2026.
Read Full Story
